FN2 Earnings Intelligence

DexCom, Inc. financials (quarterly)

DexCom, Inc. (DXCM) Key Stats (quarterly) derived from persisted SEC financial facts.

Key Stats

USD in millions, except per-share values and percentages.

Metric 3/31/20256/30/20259/30/20253/31/20266/30/20269/30/2026 est.12/30/2026 est.
Market Cap -------
- Cash $904.9$1,159$1,835.7$1,118.2$1,105--
+ Debt -------
Enterprise Value -------
Revenue $1,036$1,157.1$1,209.3$1,191.9$1,308.4$1,328.5$1,401
% Growth -----9.9%-
Gross Profit $589$688.8$731.4$750.3$830--
% Margin 56.9%59.5%60.5%62.9%63.4%--
EBITDA $193.7$275.6$306.1$322.4$386.5--
% Margin 18.7%23.8%25.3%27.0%29.5%--
Net Income $105.4$179.8$283.8$199.5$249.1--
% Margin 10.2%15.5%23.5%16.7%19.0%--
Diluted EPS $0.27$0.45$0.70$0.51$0.64$0.67$0.73
% Growth ------4.2%-
Operating Cash Flow $183.8--$525.6---
CapEx $87--$76.6---
Free Cash Flow $96.8--$449---

Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.